CDKN2A and prostate cancer: We therefore stably integrated the reporter candidates in MCF7 and DU145 (prostate cancer; p53‐ and p16‐mutated) cells using PiggyBac transposase[28] and determined the most suitable candidate based on the following criteria: 1) localization, 2) expression and 3) function of transgenic lamins.